Genetic architecture of schizophrenia: a review of major advancements

SE Legge, ML Santoro, S Periyasamy… - Psychological …, 2021 - cambridge.org
Schizophrenia is a severe psychiatric disorder with high heritability. Consortia efforts and
technological advancements have led to a substantial increase in knowledge of the genetic …

Cognitive impairment associated with schizophrenia: From pathophysiology to treatment

DC Javitt - Annual Review of Pharmacology and Toxicology, 2023 - annualreviews.org
Cognitive impairment is a core feature of schizophrenia and a major contributor to poor
functional outcomes. Methods for assessment of cognitive dysfunction in schizophrenia are …

Synergistic effects of common schizophrenia risk variants

N Schrode, SM Ho, K Yamamuro, A Dobbyn… - Nature …, 2019 - nature.com
The mechanisms by which common risk variants of small effect interact to contribute to
complex genetic disorders are unclear. Here, we apply a genetic approach, using isogenic …

Cross-platform validation of neurotransmitter release impairments in schizophrenia patient-derived NRXN1-mutant neurons

CH Pak, T Danko, VR Mirabella… - Proceedings of the …, 2021 - National Acad Sciences
Heterozygous NRXN1 deletions constitute the most prevalent currently known single-gene
mutation associated with schizophrenia, and additionally predispose to multiple other …

[HTML][HTML] Multi-ancestry transcriptome-wide association analyses yield insights into tobacco use biology and drug repurposing

F Chen, X Wang, SK Jang, BC Quach… - Nature …, 2023 - nature.com
Most transcriptome-wide association studies (TWASs) so far focus on European ancestry
and lack diversity. To overcome this limitation, we aggregated genome-wide association …

[HTML][HTML] Genome-wide Mendelian randomization identifies actionable novel drug targets for psychiatric disorders

J Liu, Y Cheng, M Li, Z Zhang, T Li… - …, 2023 - nature.com
Psychiatric disorders impose tremendous economic burden on society and are leading
causes of disability worldwide. However, only limited drugs are available for psychiatric …

Proteome-wide association study provides insights into the genetic component of protein abundance in psychiatric disorders

J Liu, X Li, XJ Luo - Biological psychiatry, 2021 - Elsevier
Background Genome-wide association studies have identified multiple risk variants for
psychiatric disorders. Nevertheless, how the risk variants confer risk of psychiatric disorders …

Genome-wide association studies of schizophrenia and bipolar disorder in a diverse cohort of US veterans

TB Bigdeli, AH Fanous, Y Li, N Rajeevan… - Schizophrenia …, 2021 - academic.oup.com
Background Schizophrenia (SCZ) and bipolar disorder (BIP) are debilitating
neuropsychiatric disorders, collectively affecting 2% of the world's population. Recognizing …

[HTML][HTML] Schizophrenia genomics: convergence on synaptic development, adult synaptic plasticity, or both?

J Hall, NJ Bray - Biological Psychiatry, 2022 - Elsevier
Large-scale genomic studies of schizophrenia have identified hundreds of genetic loci
conferring risk to the disorder. This progress offers an important route toward defining the …

[HTML][HTML] Structural and functional deviations of the hippocampus in schizophrenia and schizophrenia animal models

D Wegrzyn, G Juckel, A Faissner - International Journal of Molecular …, 2022 - mdpi.com
Schizophrenia is a grave neuropsychiatric disease which frequently onsets between the end
of adolescence and the beginning of adulthood. It is characterized by a variety of …